BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7371128)

  • 1. Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature.
    Lewy RI; Wiener L; Walinsky P; Lefer AM; Silver MJ; Smith JB
    Circulation; 1980 Jun; 61(6):1165-71. PubMed ID: 7371128
    [No Abstract]   [Full Text] [Related]  

  • 2. Thromboxane release in coronary artery disease: spontaneous versus pacing-induced angina.
    Mehta J; Mehta P; Feldman RL; Horalek C
    Am Heart J; 1984 Feb; 107(2):286-92. PubMed ID: 6695662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of thromboxane B2 levels in patients with classic and variant angina Pectoris.
    Tada M; Kuzuya T; Inoue M; Kodama K; Mishima M; Yamada M; Inui M; Abe H
    Circulation; 1981 Dec; 64(6):1107-15. PubMed ID: 7296786
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of thromboxanes in vasotonic versus vaso-occlusive angina.
    Lewy RI
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():13-6. PubMed ID: 6407435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dazoxiben on transcardiac thromboxane levels and haemodynamics in coronary heart disease.
    Hutton I; Tweddel AC; Rankin AC; Walker ID; Davidson JF
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):79S-82S. PubMed ID: 6681709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of thromboxane A2 in myocardial ischemia in patients with coronary artery disease.
    Tada M; Kuzuya T; Inoue M; Kodama K; Fukushima M; Abe H
    Adv Myocardiol; 1980; 2():397-405. PubMed ID: 7423053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of atrial pacing on intracoronary thromboxane production in coronary artery disease.
    Martin JL; Wilson JR; Burch JW; Untereker WJ; Laskey W; Ferraro N; Hirshfeld JW
    J Am Coll Cardiol; 1983 May; 1(5):1194-200. PubMed ID: 6833660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high dose aspirin on coronary hemodynamics during pacing-induced myocardial ischemia.
    Martin JL; Fisher CA; Untereker WJ; Laskey WK; Hirshfeld JW; Harken AH; Addonizio VP
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):210-5. PubMed ID: 3968305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of provocation on transcardiac thromboxane in patients with coronary artery disease.
    Hirsh PD; Firth BG; Campbell WB; Dehmer GJ; Willerson JT; Hillis LD
    Am J Cardiol; 1983 Mar; 51(5):727-33. PubMed ID: 6829431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of metabolic and vasoconstrictor stimuli on coronary vascular resistance in man.
    Mudge GH; Goldberg S; Gunther S; Mann T; Grossman W
    Circulation; 1979 Mar; 59(3):544-50. PubMed ID: 761335
    [No Abstract]   [Full Text] [Related]  

  • 11. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease.
    Hirsh PD; Hillis LD; Campbell WB; Firth BG; Willerson JT
    N Engl J Med; 1981 Mar; 304(12):685-91. PubMed ID: 6894016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early thromboxane release during pacing-induced myocardial ischemia with angiographically normal coronary arteries.
    Montalescot G; Drobinski G; Maclouf J; Lellouche F; Ankri A; Moussallem N; Eugene L; Thomas D; Grosgogeat Y
    Am Heart J; 1990 Dec; 120(6 Pt 1):1445-7. PubMed ID: 2248190
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of plasma concentrations of thromboxane B2 in Prinzmetal's variant angina and classical angina pectoris.
    Lewy RI; Wiener L; Smith JB; Walinsky P; Silver MJ; Saia J
    Clin Cardiol; 1979 Dec; 2(6):404-6. PubMed ID: 544110
    [No Abstract]   [Full Text] [Related]  

  • 14. Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.
    Robertson RM; Robertson D; Roberts LJ; Maas RL; FitzGerald GA; Friesinger GC; Oates JA
    N Engl J Med; 1981 Apr; 304(17):998-1003. PubMed ID: 7010173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of ibuprofen in pacing-induced myocardial ischemia.
    Walinsky P; Smith JB; Lefer AM; Wiener L
    Am J Cardiol; 1983 Mar; 51(5):751-4. PubMed ID: 6829434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms.
    Willerson JT; Campbell WB; Winniford MD; Schmitz J; Apprill P; Firth BG; Ashton J; Smitherman T; Bush L; Buja LM
    Am J Cardiol; 1984 Dec; 54(10):1349-54. PubMed ID: 6391133
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of timolol on platelets in coronary sinus blood and on myocardial ischemia during pacing-induced angina.
    Thaulow E; Dale J
    Acta Med Scand; 1984; 216(2):193-8. PubMed ID: 6496177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris.
    Montalescot G; Drobinski G; Maclouf J; Maillet F; Salloum J; Ankri A; Kazatchkine M; Eugène L; Thomas D; Grosgogeat Y
    Circulation; 1991 Nov; 84(5):2054-62. PubMed ID: 1934381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coronary venous liberation of lactates and the perfusional state of the subendocardium in angina caused by atrial pacing].
    Mezzetti A; Tomassetti V; Masi M; Fontana F; Barilli A; Cuppini A; Palmeggiani G; Cuccurullo F
    Boll Soc Ital Cardiol; 1981; 26(5):435-43. PubMed ID: 7340875
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-term effects of atrial versus atrio-ventricular pacing on myocardial ischaemia in coronary artery disease patients.
    Kyriakides ZS; Kremastinos DT; Kolettis TM; Livanis E; Apostolou T; Michelakakis N; Toutouzas P
    Eur Heart J; 1993 May; 14(5):607-13. PubMed ID: 8508854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.